non-small cell lung cancer

Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC).…

Medial EarlySign, a pioneering company developing AI-based clinical data solutions for early detection and prevention of high-burden diseases,…